Login / Signup

Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5.

Sean WhartonRachel L BatterhamMeena BhattaSilvio BuscemiLouise N ChristensenJuan P FriasEsteban JódarKristian KandlerGeorgia RigasThomas A WaddenW Timothy Garvey
Published in: Obesity (Silver Spring, Md.) (2023)
In adults with overweight/obesity, semaglutide 2.4 mg improved short- and longer-term control of eating associated with substantial weight loss.
Keyphrases
  • weight loss
  • bariatric surgery
  • roux en y gastric bypass
  • gastric bypass
  • weight gain
  • glycemic control
  • preterm infants
  • obese patients
  • adipose tissue
  • gestational age
  • body mass index
  • skeletal muscle